PCM
REPL icon

Penserra Capital Management’s Replimune Group REPL Stock Holding History

Penserra Capital Management’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,070
Closed -$31K – 1515
2021
Q3 		$31K Buy
1,070
+10
+0.9% +$325 ﹤0.01% 1175
2021
Q2 		$40K Buy
1,060
+10
+1% +$342 ﹤0.01% 1051
2021
Q1 		$32K Sell
1,050
-5
-0.5% -$187 ﹤0.01% 892
2020
Q4 		$40K Buy
+1,055
New +$44K ﹤0.01% 730

Other funds holding REPL

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Penserra Capital Management's REPL Position: Q4 2021 in Review

Penserra Capital Management sold out of Replimune Group (REPL) in Q4 2021, closing a stake of 1,070 shares — an estimated $31K sold.

Penserra Capital Management first reported a position in REPL in Q4 2020 and held it in 4 quarters. The position peaked at $40K in Q2 2021. 99 funds tracked by Wall St. Rank hold REPL as of Q4 2021.

  • Penserra Capital Management reported no remaining Replimune Group position as of Q4 2021 after selling out during the quarter.
  • Penserra Capital Management sold 1,070 Replimune Group shares in Q4 2021, an estimated $31K.
  • Penserra Capital Management first reported a position in Replimune Group in Q4 2020 and held it in 4 quarters.
  • Penserra Capital Management's Replimune Group position peaked at $40K in Q2 2021.
  • 99 funds tracked by Wall St. Rank held Replimune Group as of Q4 2021.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.